Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

Henke M, Mattern D, Pepe M, Bézay C, Weissenberger C, Werner M, Pajonk F.

J Clin Oncol. 2006 Oct 10;24(29):4708-13. Erratum in: J Clin Oncol. 2007 Apr 10;25(11):1457.

PMID:
17028293
2.

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

Clavo B.

J Clin Oncol. 2007 Apr 10;25(11):1447-8; author reply 1448. No abstract available.

PMID:
17416869
3.

Heat shock protein 70, erythropoietin, and cancer.

Sizer KC.

J Clin Oncol. 2007 Sep 20;25(27):4326; author reply 4326-7. No abstract available.

PMID:
17878490
4.

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H.

Lancet. 2003 Oct 18;362(9392):1255-60.

PMID:
14575968
5.

[Erythropoietin in patients with head and neck carcinomas?].

Schipper J, Henke M.

Laryngorhinootologie. 2004 May;83(5):292-7. German.

PMID:
15143446
6.

Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.

Aapro M, Leonard RC, Barnadas A, Marangolo M, Untch M, Malamos N, Mayordomo J, Reichert D, Pedrini JL, Ukarma L, Scherhag A, Burger HU.

J Clin Oncol. 2008 Feb 1;26(4):592-8. doi: 10.1200/JCO.2007.11.5378.

PMID:
18235117
7.

Role of recombinant human erythropoietin in patients of advanced cervical cancer treated "by chemoradiotherapy".

Gupta S, Singh PK, Bisth SS, Bhatt ML, Pant M, Gupta R, Singh S, Negi MP.

Cancer Biol Ther. 2009 Jan;8(1):13-7. Epub 2009 Jan 1.

PMID:
18981719
8.

Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).

Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK; Radiation Therapy Oncology Group.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1008-17. Epub 2007 Aug 23.

PMID:
17716826
9.

Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.

Hoskin PJ, Robinson M, Slevin N, Morgan D, Harrington K, Gaffney C.

J Clin Oncol. 2009 Dec 1;27(34):5751-6. doi: 10.1200/JCO.2009.22.3693. Epub 2009 Nov 2.

PMID:
19884550
10.

The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.

Rades D, Golke H, Schild SE, Kilic E.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9. Epub 2007 Oct 29.

PMID:
17967510
11.

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

Wright JR, Ung YC, Julian JA, Pritchard KI, Whelan TJ, Smith C, Szechtman B, Roa W, Mulroy L, Rudinskas L, Gagnon B, Okawara GS, Levine MN.

J Clin Oncol. 2007 Mar 20;25(9):1027-32. Epub 2007 Feb 20.

PMID:
17312332
12.

No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.

Sasaki Y, Kjellén E, Mineta H, Wennerberg J, Ekblad L.

Acta Oncol. 2009;48(7):1062-9. doi: 10.1080/02841860902913553.

PMID:
19412811
13.

Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.

Hoogsteen IJ, Peeters WJ, Marres HA, Rijken PF, van den Hoogen FJ, van der Kogel AJ, Kaanders JH.

Radiother Oncol. 2005 Aug;76(2):213-8.

PMID:
16112214
14.

[The effect of the microenvironment of head and neck cancers on tumor progression].

Lukits J.

Magy Onkol. 2009 Mar;53(1):51-9. doi: 10.1556/MOnkol.53.2009.1.8. Hungarian.

15.

Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.

Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC.

Clin Cancer Res. 2007 Aug 15;13(16):4825-31.

16.

Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells.

Belda-Iniesta C, Perona R, Carpeño Jde C, Cejas P, Casado E, Manguan-García C, Ibanez de Caceres I, Sanchez-Perez I, Andreu FB, Ferreira JA, Aguilera A, de la Peña J, Perez-Sánchez E, Madero R, Feliu J, Sereno M, González-Barón M.

Cancer Biol Ther. 2007 Oct;6(10):1600-5. Epub 2007 Jul 12.

PMID:
17938574
18.

[Anemia in head and neck cancers].

Azria D, Zouhair A, Serre A, Lemanski C, Schneider M, Ozsahin M, Dubois JB, Lartigau E; Club de Lutte Contre l'Anémie.

Bull Cancer. 2005 May 1;92(5):445-51. Review. French.

19.

Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer.

Strauss HG, Haensgen G, Dunst J, Hayward CR, Burger HU, Scherhag A, Koelbl H.

Int J Gynecol Cancer. 2008 May-Jun;18(3):515-24. Epub 2007 Jul 21.

PMID:
17645506
20.

Importance of erythropoetin receptor expression in tumour tissue for the clinical course of breast cancer.

Volgger B, Kurz K, Zöschg K, Theurl I, Ciresa-König A, Marth C, Weiss G.

Anticancer Res. 2010 Sep;30(9):3721-6.

PMID:
20944160

Supplemental Content

Support Center